Pharma & Healthcare
Global Recombinant Human Insulin Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 2442
- Pages: 93
- Figures: 115
- Views: 5
Insulin is a well-characterized peptide that can be produced byrecombinant DNA technology for human therapeutic use.
The global Recombinant Human Insulin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Recombinant Human Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Recombinant Human Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Recombinant Human Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Recombinant Human Insulin include Akron Biotech, Wockhardt, Dance Biopharm, Novo Nordisk, Gan & Lee, United Laboratories and Dongbro Pharmaceuticri, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Recombinant Human Insulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant Human Insulin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant Human Insulin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Human Insulin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Human Insulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Human Insulin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Dance Biopharm
Novo Nordisk
Gan & Lee
United Laboratories
Dongbro Pharmaceuticri
Segment by Type
by Recombinant DNA Technology Using Fermentation in Bacteria Way
by Recombinant DNA Technology Using Fermentation in Yeast Way
Segment by Application
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant Human Insulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant Human Insulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Insulin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Recombinant Human Insulin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Recombinant Human Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Recombinant Human Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Recombinant Human Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Recombinant Human Insulin include Akron Biotech, Wockhardt, Dance Biopharm, Novo Nordisk, Gan & Lee, United Laboratories and Dongbro Pharmaceuticri, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Recombinant Human Insulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant Human Insulin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant Human Insulin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Human Insulin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Human Insulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Human Insulin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Dance Biopharm
Novo Nordisk
Gan & Lee
United Laboratories
Dongbro Pharmaceuticri
Segment by Type
by Recombinant DNA Technology Using Fermentation in Bacteria Way
by Recombinant DNA Technology Using Fermentation in Yeast Way
Segment by Application
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant Human Insulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant Human Insulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Insulin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Recombinant Human Insulin Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Insulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 by Recombinant DNA Technology Using Fermentation in Bacteria Way
1.2.3 by Recombinant DNA Technology Using Fermentation in Yeast Way
1.3 Market by Application
1.3.1 Global Recombinant Human Insulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Type 1 Diabetes Mellitus
1.3.3 Type 2 Diabetes Mellitus
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Insulin Sales Estimates and Forecasts 2019-2030
2.2 Global Recombinant Human Insulin Revenue by Region
2.2.1 Global Recombinant Human Insulin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Recombinant Human Insulin Revenue by Region (2019-2024)
2.2.3 Global Recombinant Human Insulin Revenue by Region (2025-2030)
2.2.4 Global Recombinant Human Insulin Revenue Market Share by Region (2019-2030)
2.3 Global Recombinant Human Insulin Sales Estimates and Forecasts 2019-2030
2.4 Global Recombinant Human Insulin Sales by Region
2.4.1 Global Recombinant Human Insulin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Recombinant Human Insulin Sales by Region (2019-2024)
2.4.3 Global Recombinant Human Insulin Sales by Region (2025-2030)
2.4.4 Global Recombinant Human Insulin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Human Insulin Sales by Manufacturers
3.1.1 Global Recombinant Human Insulin Sales by Manufacturers (2019-2024)
3.1.2 Global Recombinant Human Insulin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Insulin in 2023
3.2 Global Recombinant Human Insulin Revenue by Manufacturers
3.2.1 Global Recombinant Human Insulin Revenue by Manufacturers (2019-2024)
3.2.2 Global Recombinant Human Insulin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Insulin Revenue in 2023
3.3 Global Key Players of Recombinant Human Insulin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Recombinant Human Insulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Insulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Insulin, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Insulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Human Insulin Sales by Type
4.1.1 Global Recombinant Human Insulin Historical Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Insulin Forecasted Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Insulin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Insulin Revenue by Type
4.2.1 Global Recombinant Human Insulin Historical Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Insulin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Insulin Price by Type
4.3.1 Global Recombinant Human Insulin Price by Type (2019-2024)
4.3.2 Global Recombinant Human Insulin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Recombinant Human Insulin Sales by Application
5.1.1 Global Recombinant Human Insulin Historical Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Insulin Forecasted Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Insulin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Insulin Revenue by Application
5.2.1 Global Recombinant Human Insulin Historical Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Insulin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Insulin Price by Application
5.3.1 Global Recombinant Human Insulin Price by Application (2019-2024)
5.3.2 Global Recombinant Human Insulin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Recombinant Human Insulin Market Size by Type
6.1.1 US & Canada Recombinant Human Insulin Sales by Type (2019-2030)
6.1.2 US & Canada Recombinant Human Insulin Revenue by Type (2019-2030)
6.2 US & Canada Recombinant Human Insulin Market Size by Application
6.2.1 US & Canada Recombinant Human Insulin Sales by Application (2019-2030)
6.2.2 US & Canada Recombinant Human Insulin Revenue by Application (2019-2030)
6.3 US & Canada Recombinant Human Insulin Market Size by Country
6.3.1 US & Canada Recombinant Human Insulin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Recombinant Human Insulin Sales by Country (2019-2030)
6.3.3 US & Canada Recombinant Human Insulin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Human Insulin Market Size by Type
7.1.1 Europe Recombinant Human Insulin Sales by Type (2019-2030)
7.1.2 Europe Recombinant Human Insulin Revenue by Type (2019-2030)
7.2 Europe Recombinant Human Insulin Market Size by Application
7.2.1 Europe Recombinant Human Insulin Sales by Application (2019-2030)
7.2.2 Europe Recombinant Human Insulin Revenue by Application (2019-2030)
7.3 Europe Recombinant Human Insulin Market Size by Country
7.3.1 Europe Recombinant Human Insulin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Recombinant Human Insulin Sales by Country (2019-2030)
7.3.3 Europe Recombinant Human Insulin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Human Insulin Market Size
8.1.1 China Recombinant Human Insulin Sales (2019-2030)
8.1.2 China Recombinant Human Insulin Revenue (2019-2030)
8.2 China Recombinant Human Insulin Market Size by Application
8.2.1 China Recombinant Human Insulin Sales by Application (2019-2030)
8.2.2 China Recombinant Human Insulin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant Human Insulin Market Size by Type
9.1.1 Asia Recombinant Human Insulin Sales by Type (2019-2030)
9.1.2 Asia Recombinant Human Insulin Revenue by Type (2019-2030)
9.2 Asia Recombinant Human Insulin Market Size by Application
9.2.1 Asia Recombinant Human Insulin Sales by Application (2019-2030)
9.2.2 Asia Recombinant Human Insulin Revenue by Application (2019-2030)
9.3 Asia Recombinant Human Insulin Sales by Region
9.3.1 Asia Recombinant Human Insulin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Recombinant Human Insulin Revenue by Region (2019-2030)
9.3.3 Asia Recombinant Human Insulin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Human Insulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Recombinant Human Insulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Akron Biotech
11.1.1 Akron Biotech Company Information
11.1.2 Akron Biotech Overview
11.1.3 Akron Biotech Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Akron Biotech Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Akron Biotech Recent Developments
11.2 Wockhardt
11.2.1 Wockhardt Company Information
11.2.2 Wockhardt Overview
11.2.3 Wockhardt Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Wockhardt Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Wockhardt Recent Developments
11.3 Dance Biopharm
11.3.1 Dance Biopharm Company Information
11.3.2 Dance Biopharm Overview
11.3.3 Dance Biopharm Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Dance Biopharm Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dance Biopharm Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novo Nordisk Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novo Nordisk Recent Developments
11.5 Gan & Lee
11.5.1 Gan & Lee Company Information
11.5.2 Gan & Lee Overview
11.5.3 Gan & Lee Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Gan & Lee Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Gan & Lee Recent Developments
11.6 United Laboratories
11.6.1 United Laboratories Company Information
11.6.2 United Laboratories Overview
11.6.3 United Laboratories Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 United Laboratories Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 United Laboratories Recent Developments
11.7 Dongbro Pharmaceuticri
11.7.1 Dongbro Pharmaceuticri Company Information
11.7.2 Dongbro Pharmaceuticri Overview
11.7.3 Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Dongbro Pharmaceuticri Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dongbro Pharmaceuticri Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Insulin Industry Chain Analysis
12.2 Recombinant Human Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Insulin Production Mode & Process
12.4 Recombinant Human Insulin Sales and Marketing
12.4.1 Recombinant Human Insulin Sales Channels
12.4.2 Recombinant Human Insulin Distributors
12.5 Recombinant Human Insulin Customers
13 Market Dynamics
13.1 Recombinant Human Insulin Industry Trends
13.2 Recombinant Human Insulin Market Drivers
13.3 Recombinant Human Insulin Market Challenges
13.4 Recombinant Human Insulin Market Restraints
14 Key Findings in The Global Recombinant Human Insulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Recombinant Human Insulin Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Insulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 by Recombinant DNA Technology Using Fermentation in Bacteria Way
1.2.3 by Recombinant DNA Technology Using Fermentation in Yeast Way
1.3 Market by Application
1.3.1 Global Recombinant Human Insulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Type 1 Diabetes Mellitus
1.3.3 Type 2 Diabetes Mellitus
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Insulin Sales Estimates and Forecasts 2019-2030
2.2 Global Recombinant Human Insulin Revenue by Region
2.2.1 Global Recombinant Human Insulin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Recombinant Human Insulin Revenue by Region (2019-2024)
2.2.3 Global Recombinant Human Insulin Revenue by Region (2025-2030)
2.2.4 Global Recombinant Human Insulin Revenue Market Share by Region (2019-2030)
2.3 Global Recombinant Human Insulin Sales Estimates and Forecasts 2019-2030
2.4 Global Recombinant Human Insulin Sales by Region
2.4.1 Global Recombinant Human Insulin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Recombinant Human Insulin Sales by Region (2019-2024)
2.4.3 Global Recombinant Human Insulin Sales by Region (2025-2030)
2.4.4 Global Recombinant Human Insulin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Human Insulin Sales by Manufacturers
3.1.1 Global Recombinant Human Insulin Sales by Manufacturers (2019-2024)
3.1.2 Global Recombinant Human Insulin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Insulin in 2023
3.2 Global Recombinant Human Insulin Revenue by Manufacturers
3.2.1 Global Recombinant Human Insulin Revenue by Manufacturers (2019-2024)
3.2.2 Global Recombinant Human Insulin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Insulin Revenue in 2023
3.3 Global Key Players of Recombinant Human Insulin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Recombinant Human Insulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Insulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Insulin, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Insulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Human Insulin Sales by Type
4.1.1 Global Recombinant Human Insulin Historical Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Insulin Forecasted Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Insulin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Insulin Revenue by Type
4.2.1 Global Recombinant Human Insulin Historical Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Insulin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Insulin Price by Type
4.3.1 Global Recombinant Human Insulin Price by Type (2019-2024)
4.3.2 Global Recombinant Human Insulin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Recombinant Human Insulin Sales by Application
5.1.1 Global Recombinant Human Insulin Historical Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Insulin Forecasted Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Insulin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Insulin Revenue by Application
5.2.1 Global Recombinant Human Insulin Historical Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Insulin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Insulin Price by Application
5.3.1 Global Recombinant Human Insulin Price by Application (2019-2024)
5.3.2 Global Recombinant Human Insulin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Recombinant Human Insulin Market Size by Type
6.1.1 US & Canada Recombinant Human Insulin Sales by Type (2019-2030)
6.1.2 US & Canada Recombinant Human Insulin Revenue by Type (2019-2030)
6.2 US & Canada Recombinant Human Insulin Market Size by Application
6.2.1 US & Canada Recombinant Human Insulin Sales by Application (2019-2030)
6.2.2 US & Canada Recombinant Human Insulin Revenue by Application (2019-2030)
6.3 US & Canada Recombinant Human Insulin Market Size by Country
6.3.1 US & Canada Recombinant Human Insulin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Recombinant Human Insulin Sales by Country (2019-2030)
6.3.3 US & Canada Recombinant Human Insulin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Human Insulin Market Size by Type
7.1.1 Europe Recombinant Human Insulin Sales by Type (2019-2030)
7.1.2 Europe Recombinant Human Insulin Revenue by Type (2019-2030)
7.2 Europe Recombinant Human Insulin Market Size by Application
7.2.1 Europe Recombinant Human Insulin Sales by Application (2019-2030)
7.2.2 Europe Recombinant Human Insulin Revenue by Application (2019-2030)
7.3 Europe Recombinant Human Insulin Market Size by Country
7.3.1 Europe Recombinant Human Insulin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Recombinant Human Insulin Sales by Country (2019-2030)
7.3.3 Europe Recombinant Human Insulin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Human Insulin Market Size
8.1.1 China Recombinant Human Insulin Sales (2019-2030)
8.1.2 China Recombinant Human Insulin Revenue (2019-2030)
8.2 China Recombinant Human Insulin Market Size by Application
8.2.1 China Recombinant Human Insulin Sales by Application (2019-2030)
8.2.2 China Recombinant Human Insulin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant Human Insulin Market Size by Type
9.1.1 Asia Recombinant Human Insulin Sales by Type (2019-2030)
9.1.2 Asia Recombinant Human Insulin Revenue by Type (2019-2030)
9.2 Asia Recombinant Human Insulin Market Size by Application
9.2.1 Asia Recombinant Human Insulin Sales by Application (2019-2030)
9.2.2 Asia Recombinant Human Insulin Revenue by Application (2019-2030)
9.3 Asia Recombinant Human Insulin Sales by Region
9.3.1 Asia Recombinant Human Insulin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Recombinant Human Insulin Revenue by Region (2019-2030)
9.3.3 Asia Recombinant Human Insulin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Human Insulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Recombinant Human Insulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Akron Biotech
11.1.1 Akron Biotech Company Information
11.1.2 Akron Biotech Overview
11.1.3 Akron Biotech Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Akron Biotech Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Akron Biotech Recent Developments
11.2 Wockhardt
11.2.1 Wockhardt Company Information
11.2.2 Wockhardt Overview
11.2.3 Wockhardt Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Wockhardt Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Wockhardt Recent Developments
11.3 Dance Biopharm
11.3.1 Dance Biopharm Company Information
11.3.2 Dance Biopharm Overview
11.3.3 Dance Biopharm Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Dance Biopharm Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dance Biopharm Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novo Nordisk Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novo Nordisk Recent Developments
11.5 Gan & Lee
11.5.1 Gan & Lee Company Information
11.5.2 Gan & Lee Overview
11.5.3 Gan & Lee Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Gan & Lee Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Gan & Lee Recent Developments
11.6 United Laboratories
11.6.1 United Laboratories Company Information
11.6.2 United Laboratories Overview
11.6.3 United Laboratories Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 United Laboratories Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 United Laboratories Recent Developments
11.7 Dongbro Pharmaceuticri
11.7.1 Dongbro Pharmaceuticri Company Information
11.7.2 Dongbro Pharmaceuticri Overview
11.7.3 Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Dongbro Pharmaceuticri Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dongbro Pharmaceuticri Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Insulin Industry Chain Analysis
12.2 Recombinant Human Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Insulin Production Mode & Process
12.4 Recombinant Human Insulin Sales and Marketing
12.4.1 Recombinant Human Insulin Sales Channels
12.4.2 Recombinant Human Insulin Distributors
12.5 Recombinant Human Insulin Customers
13 Market Dynamics
13.1 Recombinant Human Insulin Industry Trends
13.2 Recombinant Human Insulin Market Drivers
13.3 Recombinant Human Insulin Market Challenges
13.4 Recombinant Human Insulin Market Restraints
14 Key Findings in The Global Recombinant Human Insulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Recombinant Human Insulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Type I
Table 3. Major Manufacturers of Type II
Table 4. Global Recombinant Human Insulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Recombinant Human Insulin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Recombinant Human Insulin Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Recombinant Human Insulin Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Recombinant Human Insulin Revenue Market Share by Region (2019-2024)
Table 9. Global Recombinant Human Insulin Revenue Market Share by Region (2025-2030)
Table 10. Global Recombinant Human Insulin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Recombinant Human Insulin Sales by Region (2019-2024) & (g)
Table 12. Global Recombinant Human Insulin Sales by Region (2025-2030) & (g)
Table 13. Global Recombinant Human Insulin Sales Market Share by Region (2019-2024)
Table 14. Global Recombinant Human Insulin Sales Market Share by Region (2025-2030)
Table 15. Global Recombinant Human Insulin Sales by Manufacturers (2019-2024) & (g)
Table 16. Global Recombinant Human Insulin Sales Share by Manufacturers (2019-2024)
Table 17. Global Recombinant Human Insulin Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Recombinant Human Insulin Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Recombinant Human Insulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Recombinant Human Insulin Price by Manufacturers 2019-2024 (USD/mg)
Table 21. Global Recombinant Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Recombinant Human Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Insulin as of 2023)
Table 23. Global Key Manufacturers of Recombinant Human Insulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Recombinant Human Insulin, Product Offered and Application
Table 25. Global Key Manufacturers of Recombinant Human Insulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 28. Global Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 29. Global Recombinant Human Insulin Sales Share by Type (2019-2024)
Table 30. Global Recombinant Human Insulin Sales Share by Type (2025-2030)
Table 31. Global Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Recombinant Human Insulin Revenue Share by Type (2019-2024)
Table 34. Global Recombinant Human Insulin Revenue Share by Type (2025-2030)
Table 35. Recombinant Human Insulin Price by Type (2019-2024) & (USD/mg)
Table 36. Global Recombinant Human Insulin Price Forecast by Type (2025-2030) & (USD/mg)
Table 37. Global Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 38. Global Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 39. Global Recombinant Human Insulin Sales Share by Application (2019-2024)
Table 40. Global Recombinant Human Insulin Sales Share by Application (2025-2030)
Table 41. Global Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Recombinant Human Insulin Revenue Share by Application (2019-2024)
Table 44. Global Recombinant Human Insulin Revenue Share by Application (2025-2030)
Table 45. Recombinant Human Insulin Price by Application (2019-2024) & (USD/mg)
Table 46. Global Recombinant Human Insulin Price Forecast by Application (2025-2030) & (USD/mg)
Table 47. US & Canada Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 48. US & Canada Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 49. US & Canada Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 52. US & Canada Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 53. US & Canada Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Recombinant Human Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Recombinant Human Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Recombinant Human Insulin Sales by Country (2019-2024) & (g)
Table 59. US & Canada Recombinant Human Insulin Sales by Country (2025-2030) & (g)
Table 60. Europe Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 61. Europe Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 62. Europe Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 65. Europe Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 66. Europe Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Recombinant Human Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Recombinant Human Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Recombinant Human Insulin Sales by Country (2019-2024) & (g)
Table 72. Europe Recombinant Human Insulin Sales by Country (2025-2030) & (g)
Table 73. China Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 74. China Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 75. China Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 78. China Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 79. China Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 82. Asia Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 83. Asia Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 86. Asia Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 87. Asia Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Recombinant Human Insulin Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Recombinant Human Insulin Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Recombinant Human Insulin Sales by Region (2019-2024) & (g)
Table 93. Asia Recombinant Human Insulin Sales by Region (2025-2030) & (g)
Table 94. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 95. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 96. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 99. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 100. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2019-2024) & (g)
Table 106. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2025-2030) & (g)
Table 107. Akron Biotech Company Information
Table 108. Akron Biotech Description and Major Businesses
Table 109. Akron Biotech Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 110. Akron Biotech Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Akron Biotech Recent Developments
Table 112. Wockhardt Company Information
Table 113. Wockhardt Description and Major Businesses
Table 114. Wockhardt Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 115. Wockhardt Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Wockhardt Recent Developments
Table 117. Dance Biopharm Company Information
Table 118. Dance Biopharm Description and Major Businesses
Table 119. Dance Biopharm Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 120. Dance Biopharm Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Dance Biopharm Recent Developments
Table 122. Novo Nordisk Company Information
Table 123. Novo Nordisk Description and Major Businesses
Table 124. Novo Nordisk Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 125. Novo Nordisk Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Novo Nordisk Recent Developments
Table 127. Gan & Lee Company Information
Table 128. Gan & Lee Description and Major Businesses
Table 129. Gan & Lee Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 130. Gan & Lee Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Gan & Lee Recent Developments
Table 132. United Laboratories Company Information
Table 133. United Laboratories Description and Major Businesses
Table 134. United Laboratories Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 135. United Laboratories Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. United Laboratories Recent Developments
Table 137. Dongbro Pharmaceuticri Company Information
Table 138. Dongbro Pharmaceuticri Description and Major Businesses
Table 139. Dongbro Pharmaceuticri Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 140. Dongbro Pharmaceuticri Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Dongbro Pharmaceuticri Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Recombinant Human Insulin Distributors List
Table 145. Recombinant Human Insulin Customers List
Table 146. Recombinant Human Insulin Market Trends
Table 147. Recombinant Human Insulin Market Drivers
Table 148. Recombinant Human Insulin Market Challenges
Table 149. Recombinant Human Insulin Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Insulin Product Picture
Figure 2. Global Recombinant Human Insulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Recombinant Human Insulin Market Share by Type in 2023 & 2030
Figure 4. Type I Product Picture
Figure 5. Type II Product Picture
Figure 6. Global Recombinant Human Insulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Recombinant Human Insulin Market Share by Application in 2023 & 2030
Figure 8. Type 1 Diabetes Mellitus
Figure 9. Type 2 Diabetes Mellitus
Figure 10. Recombinant Human Insulin Report Years Considered
Figure 11. Global Recombinant Human Insulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Recombinant Human Insulin Revenue 2019-2030 (US$ Million)
Figure 13. Global Recombinant Human Insulin Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Recombinant Human Insulin Revenue Market Share by Region (2019-2030)
Figure 15. Global Recombinant Human Insulin Sales 2019-2030 ((g)
Figure 16. Global Recombinant Human Insulin Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Recombinant Human Insulin Sales YoY (2019-2030) & (g)
Figure 18. US & Canada Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Recombinant Human Insulin Sales YoY (2019-2030) & (g)
Figure 20. Europe Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Recombinant Human Insulin Sales YoY (2019-2030) & (g)
Figure 22. China Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Recombinant Human Insulin Sales YoY (2019-2030) & (g)
Figure 24. Asia (excluding China) Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Recombinant Human Insulin Sales YoY (2019-2030) & (g)
Figure 26. Middle East, Africa and Latin America Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Recombinant Human Insulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Recombinant Human Insulin in the World: Market Share by Recombinant Human Insulin Revenue in 2023
Figure 29. Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 31. Global Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 32. Global Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 33. Global Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Recombinant Human Insulin Revenue Share by Country (2019-2030)
Figure 39. US & Canada Recombinant Human Insulin Sales Share by Country (2019-2030)
Figure 40. U.S. Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 43. Europe Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 44. Europe Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 45. Europe Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 46. Europe Recombinant Human Insulin Revenue Share by Country (2019-2030)
Figure 47. Europe Recombinant Human Insulin Sales Share by Country (2019-2030)
Figure 48. Germany Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 49. France Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 53. China Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 54. China Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 55. China Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 56. China Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 57. Asia Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 58. Asia Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 59. Asia Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 60. Asia Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 61. Asia Recombinant Human Insulin Revenue Share by Region (2019-2030)
Figure 62. Asia Recombinant Human Insulin Sales Share by Region (2019-2030)
Figure 63. Japan Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 67. India Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Recombinant Human Insulin Sales Share by Country (2019-2030)
Figure 74. Brazil Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 79. Recombinant Human Insulin Value Chain
Figure 80. Recombinant Human Insulin Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Table 1. Global Recombinant Human Insulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Type I
Table 3. Major Manufacturers of Type II
Table 4. Global Recombinant Human Insulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Recombinant Human Insulin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Recombinant Human Insulin Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Recombinant Human Insulin Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Recombinant Human Insulin Revenue Market Share by Region (2019-2024)
Table 9. Global Recombinant Human Insulin Revenue Market Share by Region (2025-2030)
Table 10. Global Recombinant Human Insulin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Recombinant Human Insulin Sales by Region (2019-2024) & (g)
Table 12. Global Recombinant Human Insulin Sales by Region (2025-2030) & (g)
Table 13. Global Recombinant Human Insulin Sales Market Share by Region (2019-2024)
Table 14. Global Recombinant Human Insulin Sales Market Share by Region (2025-2030)
Table 15. Global Recombinant Human Insulin Sales by Manufacturers (2019-2024) & (g)
Table 16. Global Recombinant Human Insulin Sales Share by Manufacturers (2019-2024)
Table 17. Global Recombinant Human Insulin Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Recombinant Human Insulin Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Recombinant Human Insulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Recombinant Human Insulin Price by Manufacturers 2019-2024 (USD/mg)
Table 21. Global Recombinant Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Recombinant Human Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Insulin as of 2023)
Table 23. Global Key Manufacturers of Recombinant Human Insulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Recombinant Human Insulin, Product Offered and Application
Table 25. Global Key Manufacturers of Recombinant Human Insulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 28. Global Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 29. Global Recombinant Human Insulin Sales Share by Type (2019-2024)
Table 30. Global Recombinant Human Insulin Sales Share by Type (2025-2030)
Table 31. Global Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Recombinant Human Insulin Revenue Share by Type (2019-2024)
Table 34. Global Recombinant Human Insulin Revenue Share by Type (2025-2030)
Table 35. Recombinant Human Insulin Price by Type (2019-2024) & (USD/mg)
Table 36. Global Recombinant Human Insulin Price Forecast by Type (2025-2030) & (USD/mg)
Table 37. Global Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 38. Global Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 39. Global Recombinant Human Insulin Sales Share by Application (2019-2024)
Table 40. Global Recombinant Human Insulin Sales Share by Application (2025-2030)
Table 41. Global Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Recombinant Human Insulin Revenue Share by Application (2019-2024)
Table 44. Global Recombinant Human Insulin Revenue Share by Application (2025-2030)
Table 45. Recombinant Human Insulin Price by Application (2019-2024) & (USD/mg)
Table 46. Global Recombinant Human Insulin Price Forecast by Application (2025-2030) & (USD/mg)
Table 47. US & Canada Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 48. US & Canada Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 49. US & Canada Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 52. US & Canada Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 53. US & Canada Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Recombinant Human Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Recombinant Human Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Recombinant Human Insulin Sales by Country (2019-2024) & (g)
Table 59. US & Canada Recombinant Human Insulin Sales by Country (2025-2030) & (g)
Table 60. Europe Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 61. Europe Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 62. Europe Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 65. Europe Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 66. Europe Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Recombinant Human Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Recombinant Human Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Recombinant Human Insulin Sales by Country (2019-2024) & (g)
Table 72. Europe Recombinant Human Insulin Sales by Country (2025-2030) & (g)
Table 73. China Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 74. China Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 75. China Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 78. China Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 79. China Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 82. Asia Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 83. Asia Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 86. Asia Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 87. Asia Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Recombinant Human Insulin Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Recombinant Human Insulin Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Recombinant Human Insulin Sales by Region (2019-2024) & (g)
Table 93. Asia Recombinant Human Insulin Sales by Region (2025-2030) & (g)
Table 94. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2019-2024) & (g)
Table 95. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2025-2030) & (g)
Table 96. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2019-2024) & (g)
Table 99. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2025-2030) & (g)
Table 100. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2019-2024) & (g)
Table 106. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2025-2030) & (g)
Table 107. Akron Biotech Company Information
Table 108. Akron Biotech Description and Major Businesses
Table 109. Akron Biotech Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 110. Akron Biotech Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Akron Biotech Recent Developments
Table 112. Wockhardt Company Information
Table 113. Wockhardt Description and Major Businesses
Table 114. Wockhardt Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 115. Wockhardt Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Wockhardt Recent Developments
Table 117. Dance Biopharm Company Information
Table 118. Dance Biopharm Description and Major Businesses
Table 119. Dance Biopharm Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 120. Dance Biopharm Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Dance Biopharm Recent Developments
Table 122. Novo Nordisk Company Information
Table 123. Novo Nordisk Description and Major Businesses
Table 124. Novo Nordisk Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 125. Novo Nordisk Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Novo Nordisk Recent Developments
Table 127. Gan & Lee Company Information
Table 128. Gan & Lee Description and Major Businesses
Table 129. Gan & Lee Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 130. Gan & Lee Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Gan & Lee Recent Developments
Table 132. United Laboratories Company Information
Table 133. United Laboratories Description and Major Businesses
Table 134. United Laboratories Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 135. United Laboratories Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. United Laboratories Recent Developments
Table 137. Dongbro Pharmaceuticri Company Information
Table 138. Dongbro Pharmaceuticri Description and Major Businesses
Table 139. Dongbro Pharmaceuticri Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)
Table 140. Dongbro Pharmaceuticri Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Dongbro Pharmaceuticri Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Recombinant Human Insulin Distributors List
Table 145. Recombinant Human Insulin Customers List
Table 146. Recombinant Human Insulin Market Trends
Table 147. Recombinant Human Insulin Market Drivers
Table 148. Recombinant Human Insulin Market Challenges
Table 149. Recombinant Human Insulin Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Insulin Product Picture
Figure 2. Global Recombinant Human Insulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Recombinant Human Insulin Market Share by Type in 2023 & 2030
Figure 4. Type I Product Picture
Figure 5. Type II Product Picture
Figure 6. Global Recombinant Human Insulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Recombinant Human Insulin Market Share by Application in 2023 & 2030
Figure 8. Type 1 Diabetes Mellitus
Figure 9. Type 2 Diabetes Mellitus
Figure 10. Recombinant Human Insulin Report Years Considered
Figure 11. Global Recombinant Human Insulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Recombinant Human Insulin Revenue 2019-2030 (US$ Million)
Figure 13. Global Recombinant Human Insulin Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Recombinant Human Insulin Revenue Market Share by Region (2019-2030)
Figure 15. Global Recombinant Human Insulin Sales 2019-2030 ((g)
Figure 16. Global Recombinant Human Insulin Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Recombinant Human Insulin Sales YoY (2019-2030) & (g)
Figure 18. US & Canada Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Recombinant Human Insulin Sales YoY (2019-2030) & (g)
Figure 20. Europe Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Recombinant Human Insulin Sales YoY (2019-2030) & (g)
Figure 22. China Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Recombinant Human Insulin Sales YoY (2019-2030) & (g)
Figure 24. Asia (excluding China) Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Recombinant Human Insulin Sales YoY (2019-2030) & (g)
Figure 26. Middle East, Africa and Latin America Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Recombinant Human Insulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Recombinant Human Insulin in the World: Market Share by Recombinant Human Insulin Revenue in 2023
Figure 29. Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 31. Global Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 32. Global Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 33. Global Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Recombinant Human Insulin Revenue Share by Country (2019-2030)
Figure 39. US & Canada Recombinant Human Insulin Sales Share by Country (2019-2030)
Figure 40. U.S. Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 43. Europe Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 44. Europe Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 45. Europe Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 46. Europe Recombinant Human Insulin Revenue Share by Country (2019-2030)
Figure 47. Europe Recombinant Human Insulin Sales Share by Country (2019-2030)
Figure 48. Germany Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 49. France Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 53. China Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 54. China Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 55. China Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 56. China Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 57. Asia Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 58. Asia Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 59. Asia Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 60. Asia Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 61. Asia Recombinant Human Insulin Revenue Share by Region (2019-2030)
Figure 62. Asia Recombinant Human Insulin Sales Share by Region (2019-2030)
Figure 63. Japan Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 67. India Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Recombinant Human Insulin Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Recombinant Human Insulin Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Recombinant Human Insulin Sales Share by Country (2019-2030)
Figure 74. Brazil Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)
Figure 79. Recombinant Human Insulin Value Chain
Figure 80. Recombinant Human Insulin Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232